Angiosarcoma — Blood Vessel Cancer Explained

What Is Angiosarcoma?

Angiosarcoma is a blood vessel cancer — a rare type of soft tissue sarcoma that grows from the endothelial cells, the thin lining of the body's blood vessels and lymphatic channels. The name itself tells the story: angio- means vessel and -sarcoma means a cancer of connective or supporting tissue. When it arises from lymphatic vessels rather than blood vessels it is sometimes called a lymphangiosarcoma, but doctors treat both under the single heading of angiosarcoma.

Because the cells it comes from are present in every organ, angiosarcoma can occur almost anywhere. In practice, however, it shows a clear preference for a few sites: the skin of the scalp and face in older adults, the breast, and the soft tissue of an arm or leg affected by long-standing swelling. It can also develop deep inside the body — in the liver, spleen, heart, or the large blood vessels themselves — where it is harder to detect early. Angiosarcoma accounts for only a small fraction of all sarcomas, which are themselves rare, so most patients have never heard the word until they are given the diagnosis.

What sets angiosarcoma apart from many other sarcomas is its tendency to be aggressive and multifocal. Since it spreads along the inside of vessel walls, a tumour that looks like a single patch on the surface may already have microscopic satellites in the surrounding tissue. This is exactly why specialist evaluation matters from the very first appointment. You can see how angiosarcoma fits within the wider family of soft tissue cancers on our sarcoma — overview hub, and read about the full treatment pathway on the sarcoma treatment in Hyderabad page.

Where Angiosarcoma Appears — and How It Looks

Angiosarcoma does not feel or look the same everywhere. Knowing the common sites helps you understand why one person's tumour is on the scalp while another's is in the breast. These are the patterns a sarcoma specialist sees most often:

Less commonly, angiosarcoma forms deep inside the body — in the liver, spleen, heart, or major blood vessels. Deep tumours tend to cause vaguer symptoms (pain, fatigue, anaemia, or a feeling of fullness) and are often found later, which is one reason any unexplained, persistent symptom in someone with risk factors deserves proper imaging rather than reassurance alone.

Symptoms and Risk Factors to Recognise

The early signs of angiosarcoma are easy to dismiss, which is why so many cases are diagnosed late. The warning signs worth taking seriously include a bruise-like or purplish patch that grows instead of fading, a rapidly enlarging lump, a skin lesion that bleeds or ulcerates, or new swelling, discolouration, or a lump appearing within a chronically swollen limb. On the scalp and face, any "bruise" with no history of injury that persists or spreads should prompt a specialist opinion.

Certain situations raise the risk and should sharpen suspicion. Previous radiation therapy — most often radiation to the breast for an earlier cancer — is a well-recognised cause, with angiosarcoma typically appearing several years later in the treated area. Chronic lymphoedema, where lymph fluid has pooled in a limb for years, is another classic setting. Older age and long-term sun exposure account for many scalp and facial cases. Importantly, most people with these risk factors will never develop angiosarcoma — but if you have one of them and notice a persistent skin change or lump, it is exactly the situation a sarcoma specialist exists to evaluate.

How Angiosarcoma Is Diagnosed and Graded

Because angiosarcoma can imitate harmless skin changes and benign lumps, an accurate diagnosis depends on getting the right tests in the right order — and on having the tissue read by a pathologist experienced in sarcoma. At CION every suspected case is worked up methodically before any treatment decision is made.

Step 1 — Biopsy Confirms the Diagnosis

The diagnosis is made on tissue, not on a scan. A biopsy — a punch or incisional biopsy for a skin lesion, or a core needle biopsy for a deeper lump — provides the cells the pathologist needs. Under the microscope, angiosarcoma shows irregular, abnormal channels lined by malignant endothelial cells. Special immunohistochemistry stains (markers such as CD31, CD34, ERG and the MYC protein in radiation-related cases) confirm that the cancer truly arises from vessel-lining cells. This precision matters, because angiosarcoma is easily confused with other tumours and even with benign vascular lesions.

Step 2 — Imaging Maps the Extent

Once the diagnosis is confirmed, imaging shows how far the cancer reaches. MRI is the best test for soft tissue and skin tumours, defining the true edge of disease that is often invisible to the eye. A CT scan of the chest (and sometimes a PET-CT) checks whether the cancer has spread to the lungs or elsewhere, since angiosarcoma can travel through the bloodstream. For deep tumours of the liver or heart, dedicated organ imaging is added.

Step 3 — Grading and Staging

The pathologist assigns a grade based on how abnormal the cells look and how fast they are dividing; most angiosarcomas are high-grade, which is part of why they behave aggressively. The grade, the tumour's size and depth, and whether it has spread are combined into a stage that guides treatment. All of this is presented at the multidisciplinary tumour board so that surgery, radiation and chemotherapy are planned together from the start rather than one after another.

How Angiosarcoma Is Treated

Angiosarcoma is usually managed with a combination of treatments rather than any single one, because its tendency to spread along vessels and to be multifocal makes a "surgery-only" approach risky. The right mix depends on the site, size, grade, and whether the disease has spread.

There is no one-size-fits-all plan. A small, well-defined breast lesion may be cured with surgery and radiation, while widespread scalp disease may need chemotherapy and radiation together. The single most important thing is that all three specialists — surgical, radiation and medical oncology — look at your case at the same time, which is the entire purpose of a sarcoma tumour board.

Prognosis and What CION Offers

Angiosarcoma is an aggressive cancer, and honesty about that matters. Outcomes depend heavily on the site, size and grade of the tumour, whether a clear surgical margin can be achieved, and — above all — how early it is caught. A small, completely removed tumour treated promptly carries a far better outlook than a widespread or deep one found late. Because it can recur locally and spread to the lungs, long-term surveillance with regular examination and imaging is an essential part of care, not an optional extra.

This is precisely the kind of rare, fast-moving cancer where being looked after by a coordinated sarcoma team makes a real difference. At CION, every angiosarcoma case is taken to a multidisciplinary tumour board where a surgical oncologist, radiation oncologist and medical oncologist agree the sequence of treatment before anything begins — so you are not sent from one specialist to another piecing together a plan yourself. We arrange specialist sarcoma pathology review of your biopsy, MRI and CT-based staging, and a clear written explanation of your options. For families weighing a difficult diagnosis, a free written second opinion is available; you can also explore the broader sarcoma treatment in Hyderabad pathway to understand how the pieces fit together.

Why Patients Choose CION for Angiosarcoma Care

Angiosarcoma is rare and fast-moving — it needs a team that recognises it early and treats it as one coordinated plan. Here is why patients across Telangana trust CION.

Don't Wait on a Fast-Moving Cancer

With angiosarcoma, weeks matter. If you have a confirmed diagnosis or a stubborn skin patch or lump that won't settle, talk to a sarcoma specialist now — early review shapes what treatment is possible.